Meinian Onehealth
Meinian Onehealth is a private provider of preventive healthcare check-up services.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | $1.0b | Post IPO Equity | |
| Total Funding | 000k | ||
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 17 % | (7 %) | 28 % | (2 %) | 7 % | 8 % | 8 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 21 % | 14 % | 22 % | 20 % | 14 % | 15 % | 13 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 1 % | (6 %) | 5 % | 3 % | 5 % | 6 % | 7 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1 % | 1 % | 1 % | 1 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Meinian Onehealth Healthcare Holdings Co., Ltd. operates as a significant entity in China's health and medical services sector, publicly traded on the Shenzhen Stock Exchange (SZSE: 002044). Founded in 2004 by Chairman Yu Rong, the Shanghai-headquartered company has established itself as a prominent provider of health examinations and medical services. The firm was formerly known as Jiangsu Sanyou Group Co., Ltd. and listed on the SZSE in May 2005.
The company's business model is centered on providing comprehensive health check-up services to both corporate and individual clients. This core offering includes a wide array of services such as general medical examinations, disease screening, health consultations, and health assessments. Beyond examinations, Meinian Onehealth assists patients with doctor referrals and appointment bookings with specialists. The company generates revenue primarily through its professional medical examination services, which constitute the vast majority of its sales. To enhance its market reach and service delivery, the company has formed strategic partnerships with medical equipment suppliers like Medtronic and Siemens Healthineers, as well as major health insurance companies such as China Life Insurance and Ping An Insurance Group.
Meinian Onehealth operates a portfolio of four main brands: "American Year Health," "Ci Ming Physical Examination," "Ci Ming Oya," and "Meizhao Health". This multi-brand strategy allows it to cater to different segments of the market. The company has a vast network, with over 400 outlets as of mid-2018, and serves millions of customers annually. In recent years, Meinian has focused on digital transformation by implementing intelligent management platforms like the Bianque SAAS platform, LIS (Laboratory Information System), and PACS (Picture Archiving and Communication System) to improve medical quality and customer experience. The company has also engaged in strategic collaborations, such as a partnership with Alibaba's Damo Academy, to integrate AI technology for multi-cancer screening into its physical examination services.
Keywords: preventive healthcare, medical examinations, health screening, Clinics/Outpatient Services, health management, disease screening, medical services, healthcare provider, corporate wellness, individual health checks, health consultation, health assessment, doctor referrals, medical technology, digital health, AI in healthcare, China healthcare market, public company, professional prevention, medical group
